|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.379
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.377
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.322
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.247
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.243
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.201
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.193
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.176
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.163
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.154
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.144
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.137
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.135
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.135
|
|
|
|
tubulin complex biogenesis
|
GO:0072668 |
2 |
0.132
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.131
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.130
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.128
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.128
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.126
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.125
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.122
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.121
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.120
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.116
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.116
|
|
|
|
negative regulation of protein activation cascade
|
GO:2000258 |
3 |
0.112
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.110
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.110
|
|
|
|
response to nitrosative stress
|
GO:0051409 |
1 |
0.108
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.105
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.102
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.099
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.099
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.098
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.097
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.092
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.089
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.088
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.084
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.083
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.082
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.082
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.081
|
|
|
|
negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902176 |
4 |
0.080
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.076
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.076
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.075
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.075
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.074
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.073
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.071
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.070
|
|
|
|
tubulin complex assembly
|
GO:0007021 |
2 |
0.070
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.069
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.068
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.068
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.066
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.065
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.063
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.062
|
|
|
|
sodium ion export from cell
|
GO:0036376 |
1 |
0.062
|
|
|
|
nitrobenzene metabolic process
|
GO:0018916 |
1 |
0.061
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.061
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.060
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.060
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.059
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.059
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.059
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.058
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.058
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.057
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.055
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.054
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.054
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.054
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.053
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.053
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.052
|
|
|
|
negative regulation of endothelial cell apoptotic process
|
GO:2000352 |
7 |
0.051
|
|
|
|
negative regulation of oxidative stress induced cell death
|
GO:1903202 |
9 |
0.051
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.051
|
|
|
|
cellular carbohydrate catabolic process
|
GO:0044275 |
15 |
0.049
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.048
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.048
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.048
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.048
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.048
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.048
|
|
|
|
benzene containing compound metabolic process
|
GO:0042537 |
5 |
0.047
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.047
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.047
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.047
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.045
|
|
|
|
negative regulation of response to oxidative stress
|
GO:1902883 |
10 |
0.045
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.045
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.045
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.044
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.044
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.044
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.044
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.044
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.044
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.044
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.044
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.043
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.043
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.043
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.042
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.042
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.042
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.042
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.042
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.042
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.042
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.041
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.041
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.041
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.041
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.040
|
|
|
|
response to uv a
|
GO:0070141 |
1 |
0.040
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.040
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.040
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.040
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.039
|
|
|
|
positive regulation of cytokine biosynthetic process
|
GO:0042108 |
40 |
0.039
|
|
|
|
negative regulation of sodium ion transmembrane transport
|
GO:1902306 |
1 |
0.038
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.038
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.037
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.037
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.037
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.037
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.037
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.036
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.036
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.036
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.036
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.036
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.035
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.035
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.035
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.035
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.035
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
19 |
0.034
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.034
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.034
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.034
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.034
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.034
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.034
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.034
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.033
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.033
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.033
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.033
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.033
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.033
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.032
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.032
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.032
|
|
|
|
glutathione metabolic process
|
GO:0006749 |
16 |
0.031
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.031
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.031
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.031
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.031
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.031
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.031
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.030
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.030
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.030
|
|
|
|
positive regulation of peptidyl serine phosphorylation
|
GO:0033138 |
25 |
0.030
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.030
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.030
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.030
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.029
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.029
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.029
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.029
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.029
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.029
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.029
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.029
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.029
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.029
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.029
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.029
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.029
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.028
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.028
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.028
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.028
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.028
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.028
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.028
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.028
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.027
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.027
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.027
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.027
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.027
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.026
|
|
|
|
complement activation lectin pathway
|
GO:0001867 |
5 |
0.026
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.026
|
|
|
|
negative regulation of fibroblast growth factor production
|
GO:0090272 |
2 |
0.026
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.026
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.026
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.026
|
|
|
|
positive regulation of natural killer cell mediated immunity
|
GO:0002717 |
16 |
0.026
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.026
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.026
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.026
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.025
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.025
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.025
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.025
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.025
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.025
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.025
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.025
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.024
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.024
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.024
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.024
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.024
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.024
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.024
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.024
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.024
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.024
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.023
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.023
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.023
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.023
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.023
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.023
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.023
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.023
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.023
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
24 |
0.023
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.023
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.023
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.023
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.023
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.023
|
|
|
|
substantia nigra development
|
GO:0021762 |
2 |
0.023
|
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.023
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.023
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.022
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.022
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.022
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.022
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.022
|
|
|
|
renal system process involved in regulation of blood volume
|
GO:0001977 |
4 |
0.022
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.022
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.022
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.022
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.021
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.021
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.021
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.021
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.021
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.021
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.021
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.021
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.021
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.021
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.020
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
15 |
0.020
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.020
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.020
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.020
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.020
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.020
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.020
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.020
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.020
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.019
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.019
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.019
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.019
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.019
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.019
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.019
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.019
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.019
|
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
30 |
0.019
|
|
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.019
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.019
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.019
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.019
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.019
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.019
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.019
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.019
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.018
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.018
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.018
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.018
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.018
|
|
|
|
regulation of skeletal muscle contraction
|
GO:0014819 |
3 |
0.018
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.018
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.018
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.018
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.018
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.018
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.018
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.018
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.018
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.018
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.018
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.017
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.017
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.017
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.017
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.017
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.017
|
|
|
|
glucan metabolic process
|
GO:0044042 |
32 |
0.017
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.017
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
26 |
0.017
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
28 |
0.017
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.017
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.017
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.017
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.017
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.017
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.017
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.017
|
|
|
|
response to granulocyte macrophage colony stimulating factor
|
GO:0097012 |
3 |
0.017
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.017
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.017
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.017
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.017
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.017
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.017
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.017
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.017
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.016
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.016
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.016
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.016
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.016
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.016
|
|
|
|
regulation of sodium ion transmembrane transport
|
GO:1902305 |
9 |
0.016
|
|
|
|
negative regulation of cellular response to oxidative stress
|
GO:1900408 |
10 |
0.016
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.016
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.016
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.016
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.016
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.016
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.016
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.016
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.016
|
|
|
|
regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902175 |
9 |
0.016
|
|
|
|
negative regulation of sodium ion transmembrane transporter activity
|
GO:2000650 |
1 |
0.016
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.016
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.016
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.016
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.016
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.016
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.016
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.016
|
|
|
|
coenzyme a metabolic process
|
GO:0015936 |
8 |
0.016
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.016
|
|
|
|
regulation of sodium ion transmembrane transporter activity
|
GO:2000649 |
9 |
0.016
|
|
|
|
thioester metabolic process
|
GO:0035383 |
19 |
0.016
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.016
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.016
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.016
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.016
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.016
|
|
|
|
acyl coa biosynthetic process
|
GO:0071616 |
7 |
0.016
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.016
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.016
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.015
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.015
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.015
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.015
|
|
|
|
glycolytic process
|
GO:0006096 |
20 |
0.015
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.015
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.015
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.015
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
32 |
0.015
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.015
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.015
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.015
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.015
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.015
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.015
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.015
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.015
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.015
|
|
|
|
negative regulation of ion transport
|
GO:0043271 |
28 |
0.015
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.015
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.015
|
|
|
|
response to xenobiotic stimulus
|
GO:0009410 |
13 |
0.015
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.014
|
|
|
|
positive regulation of insulin like growth factor receptor signaling pathway
|
GO:0043568 |
8 |
0.014
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.014
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.014
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.014
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.014
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.014
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.014
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.014
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.014
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.014
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.014
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.014
|
|
|
|
cell cell junction assembly
|
GO:0007043 |
27 |
0.014
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.014
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.014
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.014
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.014
|
|
|
|
female genitalia morphogenesis
|
GO:0048807 |
3 |
0.014
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.014
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.014
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.014
|
|
|
|
neural nucleus development
|
GO:0048857 |
22 |
0.014
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.014
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.013
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.013
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.013
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.013
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.013
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.013
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.013
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.013
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.013
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.013
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.013
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.013
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.013
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.013
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.013
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.013
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.013
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.013
|
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.013
|
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.013
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.013
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.013
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.013
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.013
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.013
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.013
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.013
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.013
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.013
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.013
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.012
|
|
|
|
actin myosin filament sliding
|
GO:0033275 |
1 |
0.012
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.012
|
|
|
|
ribonucleoside bisphosphate metabolic process
|
GO:0033875 |
9 |
0.012
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.012
|
|
|
|
renal sodium ion transport
|
GO:0003096 |
2 |
0.012
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.012
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.012
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.012
|
|
|
|
male anatomical structure morphogenesis
|
GO:0090598 |
4 |
0.012
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.012
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.012
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.012
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.012
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.012
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.012
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.012
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.012
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.012
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.012
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.012
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.012
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.012
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.012
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.012
|
|
|
|
glycolipid biosynthetic process
|
GO:0009247 |
13 |
0.012
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.012
|
|